Risk factors
Abbott Laboratories (ABT) risk factors
Item 1A of every Abbott Laboratories 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors20 risks2 new5 dropped4 reworded
Abbott plans about $20 billion of borrowing for the Exact Sciences acquisition, making leverage and refinancing more prominent risks.
Filed Feb 20, 2026 - FY2024 10-K risk factors23 risks
Abbott faces heavy reliance on its global supply chain and complex international markets, with 61 percent of net sales outside the U.S. in 2024. Heavy regulatory scrutiny from the FDA and pricing pressures dominate the risk profile alongside $14.1 billion in consolidated indebtedness.
Filed Feb 21, 2025